English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Wednesday, December 13, 2023
China Medical System: 4 Products Have Been Newly Included or Continued to be Included in the NRDL
China Medical System: 4 Products Have Been Newly Included or Continued to be Included in the NRDL
Monday, December 4, 2023
China Medical System: NDA for Additional RA Indication of Methotrexate Injection Accepted in China
Thursday, August 24, 2023
China Medical System Gained Exclusive License of an Anti-Ischemic Stroke Class 1 Innovative Drug
China Medical System Gained Exclusive License of an Anti-Ischemic Stroke Class 1 Innovative Drug
Monday, July 31, 2023
China Medical System Once Again Received MSCI-ESG 'AA' Rating, Leading the Industry in ESG Management
China Medical System Once Again Received MSCI-ESG 'AA' Rating, Leading the Industry in ESG Management
Tuesday, May 30, 2023
China Medical System: An Innovative Drug, ILUMETRI 'Tildrakizumab Injection' Approved for Marketing in China
China Medical System: An Innovative Drug, ILUMETRI 'Tildrakizumab Injection' Approved for Marketing in China
Monday, December 19, 2022
Gelonghui Reports CMS' Successful Phase III Study of Methylthioninium Chloride Enteric-coated Sustained-release Tablets

Copyright © 2025 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575